4.7 Review

Toxicity of Antioxidant Supplements in Patients with Male Factor Infertility: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

期刊

ANTIOXIDANTS
卷 11, 期 1, 页码 -

出版社

MDPI
DOI: 10.3390/antiox11010089

关键词

adverse events; antioxidants; male infertility; meta-analysis

向作者/读者索取更多资源

Treating oxidative stress through antioxidant therapy is an appealing strategy for managing male infertility. However, there is controversial evidence regarding the toxicity of antioxidant therapy. A systematic review of available clinical evidence found that antioxidant supplementation in infertile males was associated with a significantly increased risk of nausea, headache, and dyspepsia compared to a placebo. However, the rate of treatment discontinuation due to adverse events was not significantly higher in patients taking antioxidants. A more accurate risk/benefit analysis is needed when considering antioxidant supplementation.
Treating oxidative stress through antioxidant therapy has been considered an appealing strategy in the management of male infertility. However, evidence regarding the toxicity of antioxidant therapy is controversial. We summarized the available clinical evidence on the toxicity associated with the use of antioxidants in infertile males. A systematic review was performed in March 2021. We included randomized controlled trials evaluating the incidence of adverse events in male patients with infertility receiving antioxidant therapy. Thirteen studies involving 1999 male patients were identified. Antioxidant supplementation in patients with male factor infertility was associated with a statistically significantly increased risk of nausea (Odds Ratio: 2.16, 95% Confidence Interval: 1.05-4.43, p = 0.036), headache (Odds Ratio: 3.05, 95% Confidence Interval: 1.59- 5.85 p = 0.001), and dyspepsia (Odds Ratio: 4.12, 95% Confidence Interval: 1.43-11.85, p = 0.009) compared to a placebo. Treatment discontinuation due to adverse events was not significantly higher in patients taking antioxidants compared to a placebo (Odds Ratio: 2.29, 95% Confidence Interval: 0.76-6.88, p = 0.139). When antioxidant supplementation is considered, a more accurate risk/benefit analysis is warranted.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据